EMAIL THIS PAGE TO A FRIEND

BioMed research international

Inactivation of Src-to-ezrin pathway: a possible mechanism in the ouabain-mediated inhibition of A549 cell migration.


PMID 25866790

Abstract

Ouabain, a cardiac glycoside found in plants, is primarily used in the treatment of congestive heart failure and arrhythmia because of its ability to inhibit Na(+)/K(+)-ATPase pump. Recently ouabain has been shown to exert anticancer effects but the underlying mechanism is not clear. Here, we explored the molecular mechanism by which ouabain exerts anticancer effects in human lung adenocarcinoma. Employing proteomic techniques, we found 7 proteins downregulated by ouabain in A549 including p-ezrin, a protein associated with pulmonary cancer metastasis in a dose-dependent manner. In addition, when the relative phosphorylation levels of 39 intracellular proteins were compared between control and ouabain-treated A549 cells, p-Src (Y416) was also found to be downregulated by ouabain. Furthermore, western blot revealed the ouabain-mediated downregulation of p-FAK (Y925), p-paxillin (Y118), p130CAS, and Na(+)/K(+)-ATPase subunits that have been shown to be involved in the migration of cancer cells. The inhibitory effect of ouabain and Src inhibitor PP2 on the migration of A549 cells was confirmed by Boyden chamber assay. Anticancer effects of ouabain in A549 cells appear to be related to its ability to regulate and inactivate Src-to-ezrin signaling, and proteins involved in focal adhesion such as Src, FAK, and p130CAS axis are proposed here.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

226947
3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate, 98%
C32H58N2O7S · xH2O
31573
5α-Androstan-17β-ol-3-one, VETRANAL®, analytical standard
C19H30O2
PHR1551
Acetonitrile, Pharmaceutical Secondary Standard; Certified Reference Material
C2H3N
45983
Acetonitrile, analytical standard
C2H3N
90577
Bifido Selective Supplement B, for microbiology
C2H4O2
06473
Formic acid solution, BioUltra, 1.0 M in H2O
CH2O2
1005706
Glacial acetic acid, United States Pharmacopeia (USP) Reference Standard
C2H4O2
O3125
Ouabain octahydrate, ≥95% (HPLC), powder
C29H44O12 · 8H2O
PHR1320
Residual Solvent - Acetonitrile, Pharmaceutical Secondary Standard; Certified Reference Material
C2H3N
1601340
Residual Solvent Class 2 - Acetonitrile, United States Pharmacopeia (USP) Reference Standard
C2H3N
PHR1321
Sodium chloride, Pharmaceutical Secondary Standard; Certified Reference Material
ClNa
71387
Sodium chloride, certified reference material for titrimetry, certified by BAM, ≥99.5%
ClNa
71383
Sodium chloride, tested according to Ph Eur
ClNa
T8656
Thiourea, ACS reagent, ≥99.0%
CH4N2S
T7875
Thiourea, ReagentPlus®, ≥99.0%
CH4N2S
U5128
Urea, ACS reagent, 99.0-100.5%
CH4N2O
U1250
Urea, ReagentPlus®, ≥99.5%, pellets
CH4N2O
U4883
Urea, 8 M (after reconstitution with 16 mL high purity water)
CH4N2O
U0631
Urea, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
CH4N2O
U6504
Urea, for electrophoresis
CH4N2O
15604
Urea, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%, 99.0-101.0% (calc. on dry substance)
CH4N2O
33247
Urea, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
CH4N2O
51456
Urea, BioUltra, for molecular biology, ≥99% (T)
CH4N2O
U4884
Urea, meets USP testing specifications
CH4N2O
56180
Urea, analytical standard
CH4N2O
1706698
Urea, United States Pharmacopeia (USP) Reference Standard
CH4N2O
U0600000
Urea, European Pharmacopoeia (EP) Reference Standard
CH4N2O
51457
Urea solution, BioUltra, ~8 M in H2O
CH4N2O
U7129
Urea solution, 40 % (w/v) in H2O
CH4N2O
08582
Urea solution, for microbiology, 40% in H2O
CH4N2O